The FDA has approved the first new drug in decades to treat chronic schizophrenia, which is effective and has fewer side effects than existing treatments, and could be beneficial to the Black community, where the rate of schizophrenia diagnoses is estimated to be up to five times higher than in the White community.
The post New schizophrenia drug may have milder side effects appeared first on AFRO American Newspapers.
